52, avenue André Morizet92513 Boulogne-Billancourt Cedex - France

Phone: +33 (1) 41 10 50 00 – Fax: +33 (1) 41 10 50 20www.e-cancer.fr

France National Cancer Institute (INCa) is the preeminent health and scienceagency in charge of cancer control. Created under the Public Health Act of9August 2004, it is attached to both Ministries of Health and Research.

INSTITUT NATIONAL DU CANCERLet's spur progress against cancer

Prevention – Screening – Care – Research

www.e-cancer.fr

PLAINCAGB13

INSTITUT NATIONAL DU CANCER

INCa’S RESOURCES

The INCa board of directors is made up of representativesof the core GIP members and of eight qualified individuals.It is supported by an International Scientific Advisory

Board and three consultative bodies, namely an ethics commit-tee, an audit committee and a users' and professionals' com-mittee.

INCa has an annual budget of approximately €100 million. Mostof it is received from the Ministries of Health and Research, contri-butions from other GIP members and funds from partnerships withpublic and private organisations. About half of this budget is allo-cated to research funding. The rest is allocated to healthcare ini-tiatives, public health and public information.

INCa has 150 employees, and works with several hundred out-side experts each year to contribute to its works.

➔ We take care to direct our efforts to best meet the needs andexpectations of patients, the general population, and health-care and research professionals.

➔ We are renewing our quality insurance system for expertise.

➔ We are committed to developing a systematic approach for eval-uating our actions and their impact.

➔ We are developing strategies for the early identification of inno-vation, and for supporting and disseminating innovation for thebenefit of patients and the general public.

➔ We are implementing an integrated strategy that allows thesynergistic deployment of tools for public health, organisationof care, and advances in research.

➔ As a unifying force in the fight against cancer, we act in part-nership with the other stakeholders.

INCa’S COMMITMENTS

Plaquette Instit-210X280-Anglais_INCa 07/01/14 14:29 Page1

52, avenue André Morizet92513 Boulogne-Billancourt Cedex - France

Phone: +33 (1) 41 10 50 00 – Fax: +33 (1) 41 10 50 20www.e-cancer.fr

France National Cancer Institute (INCa) is the preeminent health and scienceagency in charge of cancer control. Created under the Public Health Act of9August 2004, it is attached to both Ministries of Health and Research.

INSTITUT NATIONAL DU CANCERLet's spur progress against cancer

Prevention – Screening – Care – Research

www.e-cancer.fr

PLAINCAGB13

INSTITUT NATIONAL DU CANCER

INCa’S RESOURCES

The INCa board of directors is made up of representativesof the core GIP members and of eight qualified individuals.It is supported by an International Scientific Advisory

Board and three consultative bodies, namely an ethics commit-tee, an audit committee and a users' and professionals' com-mittee.

INCa has an annual budget of approximately €100 million. Mostof it is received from the Ministries of Health and Research, contri-butions from other GIP members and funds from partnerships withpublic and private organisations. About half of this budget is allo-cated to research funding. The rest is allocated to healthcare ini-tiatives, public health and public information.

INCa has 150 employees, and works with several hundred out-side experts each year to contribute to its works.

➔ We take care to direct our efforts to best meet the needs andexpectations of patients, the general population, and health-care and research professionals.

➔ We are renewing our quality insurance system for expertise.

➔ We are committed to developing a systematic approach for eval-uating our actions and their impact.

➔ We are developing strategies for the early identification of inno-vation, and for supporting and disseminating innovation for thebenefit of patients and the general public.

➔ We are implementing an integrated strategy that allows thesynergistic deployment of tools for public health, organisationof care, and advances in research.

➔ As a unifying force in the fight against cancer, we act in part-nership with the other stakeholders.

INCa’S COMMITMENTS

Plaquette Instit-210X280-Anglais_INCa 07/01/14 14:29 Page1

RESEARCH

www.e-cancer.fr

French National Cancer Institute Scientifi c Report

2011-2012

Mesures 1, 2, 3, 4 et 5

INCa’S MISSIONS

AN INTEGRATED APPROACH TO ACCELERATE PROGRESS

Within this context, the INCa provides inte-grated undertakings in all dimensions (health,scientific, social and economic) and areas of

intervention (prevention, screening, care and research)associated with malignant pathologies.

The INCa works at the interface with patients, their friendsand families, the healthcare system users, the general pub-lic, healthcare professionals, researchers, experts and deci-sion-makers to catalyse progress .

I NCa is a public interest group (GIP)which brings together State represen-tatives, large NGOs, health insurance

funds, research organisations and hos-pital federations.1

These stakeholders share a common goalof reducing the incidence of avoidablecancers and the number of cancer deaths,improving the quality of life of people withcancer during and after their illness, andreducing inequalities related to cancer.

The challenge:

➔ Over 365,000 people newly diagnosed with cancer each year and147,000 deaths in 2011.

➔ Social issues on rise (return to work , insurance, disability) due toimproved survival (the 5-year relative survival rate from all types of canceris 52%).

➔Personalized care as a result of major advances in recent years.

➔ Financial constraints on the health system and demographic pressureson professionals.

➔ Challenges in knowledge-based decision-making.

SHARED GOALS

1. Constituent partners of the INCa GIP: Ministry of Research, Ministry of Health, National Cancer League, ARC Foundation for Cancer Research, RSI (Independent Workers' Health Insurance), CNAMTS (National Health Insurance Fund for Salaried Workers), MSA (Agricultural Social Insurance Fund),INSERM (National Health and Medical Research Institute), CNRS (National Centre for Scientific Research), FHP (Federation of Private Hospitals), FEHAP (Federation of Private Hospitals and Healthcare Assistance), FFCLCC (Federation of Cancer Care Centres).

TO COORDINATE CANCERCONTROL ACTIVITIESINCa partners with the main non-profitand institutional stakeholders; leads thenetworks of national expert centers(regional oncology networks and can-céropôles; structures cancer control withthe Regional Health Agencies (ARS);develops international collaborations;implements and monitors the Cancercontrol Plan.

TO INITIATE AND SUPPORTSCIENTIFIC, MEDICAL,TECHNOLOGICAL ANDORGANISATIONALINNOVATIONEach year INCa launches competitivecalls for proposals in all areas of cancerresearch, healthcare organisation andpublic health, and follows up selectedand funded projects.

TO CONTRIBUTE TO THE ORGANISATIONALFRAMEWORKINCa is instrumental in the organisationof screening, care and research. It enactsguidelines, procedures for designationand certification, and follows up andassesses cancer control activities.

Examples : definition of criteria for certification ofhealthcare facilities authorised to treat cancer; struc-turing and follow up of activities for rare cancers expertcentres, molecular genetics platforms, early phase clin-ical trial centres, integrated cancer research sites, etc.

TO PRODUCE EXPERTISEINCa produces expertises, recommen-dations, guidelines, reports and opin-ions, mainly at the request of the Min-istry of Health. They are intended to helpdecision-makers, guide professionals andprovide cancer information to patientsand the general public.

Examples: Reference Sheets on risk factors for can-cer, recommendations on clinical practice for health-care professionals, summary of procedures for mov-ing toward the use of immunological tests for screening,report on UV tanning facilities and cancer risks, etc.

TO PRODUCE, ANALYSEAND EVALUATE DATAINCa is expanding the observation of can-cers through surveillance tools, studies,analysis and dissemination of data in allareas of cancer research.

Examples: the Nota Bene Cancer literature surveillancebulletin, the cancer data portal, annual publication onthe cancer situation, regional data sheets, monitoringof chemotherapy and radiotherapy activity, mana-gement of the clinical trials registry, interactive map ofcancer care providers, etc.

TO PROMOTE KNOWLEDGEUPTAKE AND GOODPRACTICESTraining tools, information campaigns,organisation of colloquia, scientific pub-lications, attendance at shows, internetsite—INCa uses all available media topromote the knowledge uptake and goodpractices implementation by the, health-care system, the general public, health-care professionals and researchers.

INCa’S PRIORITIES

RESEARCH

➔ To support emerging fields, i.e. genomic studies, exper-imental study models, biology and immunology.

➔ To translate fundamental discoveries into advances forthe benefit of the population and for patients—diagnostictools, personalised treatments, and quality of life—as quicklyas possible.

➔ To increase the availability of biological and clinicalresources to researchers.

➔ To develop clinical trials in order to find effective treatments.

PUBLIC HEALTH

➔ To improve knowledge on cancer risk factors.

➔ To promote behaviours changes to reduce the inci-dence of avoidable cancers.

➔ To define and adapt screening strategies according topeople's level of risk for cancer.

➔ To continuously optimise the organisation of screen-ing, by assessing and incorporating scientific and tech-nical advances.

➔ To disseminate information on cancer that is reliableand succinct.

CARE

➔ To improve the coordination of patient-centred care, inthe context of a personalised care pathway

➔ To guarantee equal access to quality care.

➔ To develop relavant care procedures for people with rarecancers, people with a genetic predisposition, elderlypeople, children and adolescents.

➔ To support the evolvement of career paths in the cancerfield.

➔ To promote the improvement in the quality of life duringand after the disease.

Plaquette Instit-210X280-Anglais_INCa 07/01/14 14:29 Page4

RESEARCH

www.e-cancer.fr

French National Cancer Institute Scientifi c Report

2011-2012

Mesures 1, 2, 3, 4 et 5

INCa’S MISSIONS

AN INTEGRATED APPROACH TO ACCELERATE PROGRESS

Within this context, the INCa provides inte-grated undertakings in all dimensions (health,scientific, social and economic) and areas of

intervention (prevention, screening, care and research)associated with malignant pathologies.

The INCa works at the interface with patients, their friendsand families, the healthcare system users, the general pub-lic, healthcare professionals, researchers, experts and deci-sion-makers to catalyse progress .

I NCa is a public interest group (GIP)which brings together State represen-tatives, large NGOs, health insurance

funds, research organisations and hos-pital federations.1

These stakeholders share a common goalof reducing the incidence of avoidablecancers and the number of cancer deaths,improving the quality of life of people withcancer during and after their illness, andreducing inequalities related to cancer.

The challenge:

➔ Over 365,000 people newly diagnosed with cancer each year and147,000 deaths in 2011.

➔ Social issues on rise (return to work , insurance, disability) due toimproved survival (the 5-year relative survival rate from all types of canceris 52%).

➔Personalized care as a result of major advances in recent years.

➔ Financial constraints on the health system and demographic pressureson professionals.

➔ Challenges in knowledge-based decision-making.

SHARED GOALS

1. Constituent partners of the INCa GIP: Ministry of Research, Ministry of Health, National Cancer League, ARC Foundation for Cancer Research, RSI (Independent Workers' Health Insurance), CNAMTS (National Health Insurance Fund for Salaried Workers), MSA (Agricultural Social Insurance Fund),INSERM (National Health and Medical Research Institute), CNRS (National Centre for Scientific Research), FHP (Federation of Private Hospitals), FEHAP (Federation of Private Hospitals and Healthcare Assistance), FFCLCC (Federation of Cancer Care Centres).

TO COORDINATE CANCERCONTROL ACTIVITIESINCa partners with the main non-profitand institutional stakeholders; leads thenetworks of national expert centers(regional oncology networks and can-céropôles; structures cancer control withthe Regional Health Agencies (ARS);develops international collaborations;implements and monitors the Cancercontrol Plan.

TO INITIATE AND SUPPORTSCIENTIFIC, MEDICAL,TECHNOLOGICAL ANDORGANISATIONALINNOVATIONEach year INCa launches competitivecalls for proposals in all areas of cancerresearch, healthcare organisation andpublic health, and follows up selectedand funded projects.

TO CONTRIBUTE TO THE ORGANISATIONALFRAMEWORKINCa is instrumental in the organisationof screening, care and research. It enactsguidelines, procedures for designationand certification, and follows up andassesses cancer control activities.

Examples : definition of criteria for certification ofhealthcare facilities authorised to treat cancer; struc-turing and follow up of activities for rare cancers expertcentres, molecular genetics platforms, early phase clin-ical trial centres, integrated cancer research sites, etc.

TO PRODUCE EXPERTISEINCa produces expertises, recommen-dations, guidelines, reports and opin-ions, mainly at the request of the Min-istry of Health. They are intended to helpdecision-makers, guide professionals andprovide cancer information to patientsand the general public.

Examples: Reference Sheets on risk factors for can-cer, recommendations on clinical practice for health-care professionals, summary of procedures for mov-ing toward the use of immunological tests for screening,report on UV tanning facilities and cancer risks, etc.

TO PRODUCE, ANALYSEAND EVALUATE DATAINCa is expanding the observation of can-cers through surveillance tools, studies,analysis and dissemination of data in allareas of cancer research.

Examples: the Nota Bene Cancer literature surveillancebulletin, the cancer data portal, annual publication onthe cancer situation, regional data sheets, monitoringof chemotherapy and radiotherapy activity, mana-gement of the clinical trials registry, interactive map ofcancer care providers, etc.

TO PROMOTE KNOWLEDGEUPTAKE AND GOODPRACTICESTraining tools, information campaigns,organisation of colloquia, scientific pub-lications, attendance at shows, internetsite—INCa uses all available media topromote the knowledge uptake and goodpractices implementation by the, health-care system, the general public, health-care professionals and researchers.

INCa’S PRIORITIES

RESEARCH

➔ To support emerging fields, i.e. genomic studies, exper-imental study models, biology and immunology.

➔ To translate fundamental discoveries into advances forthe benefit of the population and for patients—diagnostictools, personalised treatments, and quality of life—as quicklyas possible.

➔ To increase the availability of biological and clinicalresources to researchers.

➔ To develop clinical trials in order to find effective treatments.

PUBLIC HEALTH

➔ To improve knowledge on cancer risk factors.

➔ To promote behaviours changes to reduce the inci-dence of avoidable cancers.

➔ To define and adapt screening strategies according topeople's level of risk for cancer.

➔ To continuously optimise the organisation of screen-ing, by assessing and incorporating scientific and tech-nical advances.

➔ To disseminate information on cancer that is reliableand succinct.

CARE

➔ To improve the coordination of patient-centred care, inthe context of a personalised care pathway

➔ To guarantee equal access to quality care.

➔ To develop relavant care procedures for people with rarecancers, people with a genetic predisposition, elderlypeople, children and adolescents.

➔ To support the evolvement of career paths in the cancerfield.

➔ To promote the improvement in the quality of life duringand after the disease.

Plaquette Instit-210X280-Anglais_INCa 07/01/14 14:29 Page4

RESEARCH

www.e-cancer.fr

French National Cancer Institute Scientifi c Report

2011-2012

Mesures 1, 2, 3, 4 et 5

INCa’S MISSIONS

AN INTEGRATED APPROACH TO ACCELERATE PROGRESS

Within this context, the INCa provides inte-grated undertakings in all dimensions (health,scientific, social and economic) and areas of

intervention (prevention, screening, care and research)associated with malignant pathologies.

The INCa works at the interface with patients, their friendsand families, the healthcare system users, the general pub-lic, healthcare professionals, researchers, experts and deci-sion-makers to catalyse progress .

I NCa is a public interest group (GIP)which brings together State represen-tatives, large NGOs, health insurance

funds, research organisations and hos-pital federations.1

These stakeholders share a common goalof reducing the incidence of avoidablecancers and the number of cancer deaths,improving the quality of life of people withcancer during and after their illness, andreducing inequalities related to cancer.

The challenge:

➔ Over 365,000 people newly diagnosed with cancer each year and147,000 deaths in 2011.

➔ Social issues on rise (return to work , insurance, disability) due toimproved survival (the 5-year relative survival rate from all types of canceris 52%).

➔Personalized care as a result of major advances in recent years.

➔ Financial constraints on the health system and demographic pressureson professionals.

➔ Challenges in knowledge-based decision-making.

SHARED GOALS

1. Constituent partners of the INCa GIP: Ministry of Research, Ministry of Health, National Cancer League, ARC Foundation for Cancer Research, RSI (Independent Workers' Health Insurance), CNAMTS (National Health Insurance Fund for Salaried Workers), MSA (Agricultural Social Insurance Fund),INSERM (National Health and Medical Research Institute), CNRS (National Centre for Scientific Research), FHP (Federation of Private Hospitals), FEHAP (Federation of Private Hospitals and Healthcare Assistance), FFCLCC (Federation of Cancer Care Centres).

TO COORDINATE CANCERCONTROL ACTIVITIESINCa partners with the main non-profitand institutional stakeholders; leads thenetworks of national expert centers(regional oncology networks and can-céropôles; structures cancer control withthe Regional Health Agencies (ARS);develops international collaborations;implements and monitors the Cancercontrol Plan.

TO INITIATE AND SUPPORTSCIENTIFIC, MEDICAL,TECHNOLOGICAL ANDORGANISATIONALINNOVATIONEach year INCa launches competitivecalls for proposals in all areas of cancerresearch, healthcare organisation andpublic health, and follows up selectedand funded projects.

TO CONTRIBUTE TO THE ORGANISATIONALFRAMEWORKINCa is instrumental in the organisationof screening, care and research. It enactsguidelines, procedures for designationand certification, and follows up andassesses cancer control activities.

Examples : definition of criteria for certification ofhealthcare facilities authorised to treat cancer; struc-turing and follow up of activities for rare cancers expertcentres, molecular genetics platforms, early phase clin-ical trial centres, integrated cancer research sites, etc.

TO PRODUCE EXPERTISEINCa produces expertises, recommen-dations, guidelines, reports and opin-ions, mainly at the request of the Min-istry of Health. They are intended to helpdecision-makers, guide professionals andprovide cancer information to patientsand the general public.

Examples: Reference Sheets on risk factors for can-cer, recommendations on clinical practice for health-care professionals, summary of procedures for mov-ing toward the use of immunological tests for screening,report on UV tanning facilities and cancer risks, etc.

TO PRODUCE, ANALYSEAND EVALUATE DATAINCa is expanding the observation of can-cers through surveillance tools, studies,analysis and dissemination of data in allareas of cancer research.

Examples: the Nota Bene Cancer literature surveillancebulletin, the cancer data portal, annual publication onthe cancer situation, regional data sheets, monitoringof chemotherapy and radiotherapy activity, mana-gement of the clinical trials registry, interactive map ofcancer care providers, etc.

TO PROMOTE KNOWLEDGEUPTAKE AND GOODPRACTICESTraining tools, information campaigns,organisation of colloquia, scientific pub-lications, attendance at shows, internetsite—INCa uses all available media topromote the knowledge uptake and goodpractices implementation by the, health-care system, the general public, health-care professionals and researchers.

INCa’S PRIORITIES

RESEARCH

➔ To support emerging fields, i.e. genomic studies, exper-imental study models, biology and immunology.

➔ To translate fundamental discoveries into advances forthe benefit of the population and for patients—diagnostictools, personalised treatments, and quality of life—as quicklyas possible.

➔ To increase the availability of biological and clinicalresources to researchers.

➔ To develop clinical trials in order to find effective treatments.

PUBLIC HEALTH

➔ To improve knowledge on cancer risk factors.

➔ To promote behaviours changes to reduce the inci-dence of avoidable cancers.

➔ To define and adapt screening strategies according topeople's level of risk for cancer.

➔ To continuously optimise the organisation of screen-ing, by assessing and incorporating scientific and tech-nical advances.

➔ To disseminate information on cancer that is reliableand succinct.

CARE

➔ To improve the coordination of patient-centred care, inthe context of a personalised care pathway

➔ To guarantee equal access to quality care.

➔ To develop relavant care procedures for people with rarecancers, people with a genetic predisposition, elderlypeople, children and adolescents.

➔ To support the evolvement of career paths in the cancerfield.

➔ To promote the improvement in the quality of life duringand after the disease.

Plaquette Instit-210X280-Anglais_INCa 07/01/14 14:29 Page4

52, avenue André Morizet92513 Boulogne-Billancourt Cedex - France

Phone: +33 (1) 41 10 50 00 – Fax: +33 (1) 41 10 50 20www.e-cancer.fr

France National Cancer Institute (INCa) is the preeminent health and scienceagency in charge of cancer control. Created under the Public Health Act of9August 2004, it is attached to both Ministries of Health and Research.

INSTITUT NATIONAL DU CANCERLet's spur progress against cancer

Prevention – Screening – Care – Research

www.e-cancer.fr

PLAINCAGB13

INSTITUT NATIONAL DU CANCER

INCa’S RESOURCES

The INCa board of directors is made up of representativesof the core GIP members and of eight qualified individuals.It is supported by an International Scientific Advisory

Board and three consultative bodies, namely an ethics commit-tee, an audit committee and a users' and professionals' com-mittee.

INCa has an annual budget of approximately €100 million. Mostof it is received from the Ministries of Health and Research, contri-butions from other GIP members and funds from partnerships withpublic and private organisations. About half of this budget is allo-cated to research funding. The rest is allocated to healthcare ini-tiatives, public health and public information.

INCa has 150 employees, and works with several hundred out-side experts each year to contribute to its works.

➔ We take care to direct our efforts to best meet the needs andexpectations of patients, the general population, and health-care and research professionals.

➔ We are renewing our quality insurance system for expertise.

➔ We are committed to developing a systematic approach for eval-uating our actions and their impact.

➔ We are developing strategies for the early identification of inno-vation, and for supporting and disseminating innovation for thebenefit of patients and the general public.

➔ We are implementing an integrated strategy that allows thesynergistic deployment of tools for public health, organisationof care, and advances in research.

➔ As a unifying force in the fight against cancer, we act in part-nership with the other stakeholders.

INCa’S COMMITMENTS

Plaquette Instit-210X280-Anglais_INCa 07/01/14 14:29 Page1